Literature DB >> 27350576

A Group of Weakly Bound to Neurons Extracellular Metallopeptidases (NEMPs).

Ekaterina S Kropotova1,2, Mark I Mosevitsky3,4.   

Abstract

We have found that isolated from mammalian brain (rat, bovine) axonal endings (synaptosomes) degrade peptides of different composition. With the use of low concentration of non ionic detergent Triton X-100 (0.05-0.1 %) four low specific metallopeptidases were detached from synaptosomes. These peptidases were named Neuronal EctoMetalloPeptidases (NEMPs). Using specially designed test-peptides they were characterized as: carboxypeptidase (NEMP1), aminopeptidase (NEMP2) and endopeptidases NEMP3 and NEMP4. NEMPs are true peptidases (oligopeptidases), because they are able efficiently degrade peptides containing less than 40 amino acid residues. Specific properties of some NEMPs were revealed. NEMP1 is a small protein (molecular mass of about 10 kDa), which tends to dynamic oligomerization. NEMP3 needs activation. Some amino acids activate this enzyme. As far as we know, these properties were not ascribed to the known similarly localized peptidases. A possible physiological function of low specific NEMPs is participation in control of wide range of neuropeptides secreted in the synaptic cleft. However, NEMPs also due to their low specificity can destroy introduced in brain therapeutic peptides. The data obtained in this study open new opportunities for the protection of synthetic therapeutic peptides in brain and, possibly, in other tissues.

Entities:  

Keywords:  Axonal ends; Extracellular peptidases; Neuropeptides; Protection of therapeutic peptides; Synaptosomes

Mesh:

Substances:

Year:  2016        PMID: 27350576     DOI: 10.1007/s11064-016-1979-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  31 in total

1.  Enzymatic properties of human aminopeptidase A. Regulation of its enzymatic activity by calcium and angiotensin IV.

Authors:  Yoshikuni Goto; Akira Hattori; Yasuhiro Ishii; Shigehiko Mizutani; Masafumi Tsujimoto
Journal:  J Biol Chem       Date:  2006-06-21       Impact factor: 5.157

2.  Aminopeptidase P from rat brain. Purification and action on bioactive peptides.

Authors:  H T Harbeck; R Mentlein
Journal:  Eur J Biochem       Date:  1991-06-01

3.  Enkephalin metabolism by microglial aminopeptidase N (CD13).

Authors:  R Lucius; J Sievers; R Mentlein
Journal:  J Neurochem       Date:  1995-04       Impact factor: 5.372

4.  Substance P and [Leu]enkephalin are hydrolyzed by an enzyme in pig caudate synaptic membranes that is identical with the endopeptidase of kidney microvilli.

Authors:  R Matsas; I S Fulcher; A J Kenny; A J Turner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

5.  Substrate specificity of human carboxypeptidase A6.

Authors:  Peter J Lyons; Lloyd D Fricker
Journal:  J Biol Chem       Date:  2010-09-20       Impact factor: 5.157

Review 6.  Proline specific peptidases.

Authors:  D F Cunningham; B O'Connor
Journal:  Biochim Biophys Acta       Date:  1997-12-05

7.  Rat kidney endopeptidase 24.16. Purification, physico-chemical characteristics and differential specificity towards opiates, tachykinins and neurotensin-related peptides.

Authors:  H Barelli; J P Vincent; F Checler
Journal:  Eur J Biochem       Date:  1993-01-15

8.  Thyrotropin-releasing hormone regulates the diurnal variation of pyroglutamyl aminopeptidase II activity in the male rat adenohypophysis.

Authors:  Miguel Angel Vargas; Rosa María Uribe; Miguel Cisneros; Fidelia Romero; Sergio González; Patricia Joseph-Bravo; Jean-Louis Charli
Journal:  Eur J Endocrinol       Date:  2002-09       Impact factor: 6.664

Review 9.  Neprilysin and amyloid beta peptide degradation.

Authors:  Louis B Hersh; David W Rodgers
Journal:  Curr Alzheimer Res       Date:  2008-04       Impact factor: 3.498

Review 10.  Amyloid-degrading enzymes as therapeutic targets in Alzheimer's disease.

Authors:  Natalia N Nalivaeva; Lilia R Fisk; Nikolai D Belyaev; Anthony J Turner
Journal:  Curr Alzheimer Res       Date:  2008-04       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.